Finland· FI-REL-REL516
Librax
A clidinium mit psycholeptika product containing clidinium bromide + chlordiazepoxide, registered in Finland by Viatris Oy. The same ATC class is registered in 5 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Clidinium mit psycholeptika is registered in 5 of 19 countries.
Countries holding a registration under ATC A03CA02 (clidinium mit psycholeptika), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Clidinium mit psycholeptika · ATC A03CA02
5 / 19 countries
- Canada
- Finlandprice
- Icelandprice
- Norwayprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Clidinium bromide + Chlordiazepoxide
- Manufacturer
- Viatris Oy
- Country
- Finland (FI)
- ATC code
- A03CA02
- ATC class
- Clidinium mit Psycholeptika
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Clidinium mit psycholeptika in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDEMicro Labs Limited
- FranceLIBRAX, comprimé enrobéDIFARMED (ESPAGNE)
- NorwayLibraxMeda
- CanadaLIBRAXBAUSCH HEALTH, CANADA INC.
- United KingdomLibrax capsulesImported (United States)
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Cyprus · Bralix, Librax
- France · Librax
- Greece · Librax
- Iceland · Librax
- Portugal · Librax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6c44de39-699e-4e5b-bd52-54cb04eec545 GET /v1/drugs/6c44de39-699e-4e5b-bd52-54cb04eec545?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "4",
"form": "tabletti, päällystetty",
"route": "Suun kautta",
"ddd_unit": "ED",
"strength": "5 mg / 2.5 mg",
"atc_label": "klidiini ja psyykenlääke",
"ma_number": "4750",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL516",
"authorised_at": "1967-05-24"
}See everything about clidinium mit psycholeptika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.